<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7916812/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Important micro-algae derived components in pharmaceutical applications.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Compound</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Microalgae Species</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Isolation/Extraction Method</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Cell/Virus/Animal Model/Clinical Patient</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Effect</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-5-.">References</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td colspan="6" align="center" valign="middle" rowspan="1">Anticancer Agents</td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Lutein</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Chlorella vulgaris</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Ethanol extraction and partitioned with hexane</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Colon cancer (HCT116) cells</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Antiproliferative effect IC 
    <sub>50</sub> = 40.31 ± 4.43 µg/mL 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B31-molecules-26-00943" ref-type="bibr">31</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Violaxanthin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Dunaliella tertiolecta</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Dichloromethane extract</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Human mammary carcinoma cell lines (MCF-7) and human prostatic carcinoma (LNCaP) cells</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Potent inhibition of MCF-7 and LNCaP cells at growth inhibition (GI 
    <sub>50</sub>) of 56.1 and 60.9 µg/mL, respectively 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B32-molecules-26-00943" ref-type="bibr">32</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Fucoxanthin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Phaeodactylum tricornutum</i> UTEX 640 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">ressurized liquid extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Human liver cancer cell lines (Hep-G2), Human colon cancer (Caco-2) cells and HeLa cell line</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">An inhibitory effect of up to 58% was measured in Hep-G2 cells. In HeLa and Caco-2 cells, the effect was stronger than that of the positive control with a final concentration of 5% DMSO.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B33-molecules-26-00943" ref-type="bibr">33</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Phycocyanin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Spirulina platensis</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Freeze-thawing followed by solvent extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Liver cancer (Hep-G2) cancer cells, Non-small cell lung cancer (NSCLC)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Inhibited liver cancer cells and leukemia cells. 
    <br/>Induce apoptosis in H460 cells reaching 3.72 ± 0.98% and suppress growth of NSCLC cells 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B34-molecules-26-00943" ref-type="bibr">34</a>, 
    <a rid="B35-molecules-26-00943" ref-type="bibr">35</a>, 
    <a rid="B36-molecules-26-00943" ref-type="bibr">36</a>, 
    <a rid="B37-molecules-26-00943" ref-type="bibr">37</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Phycocyanin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Spirulina platensis</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Supercritical fluid extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Human lung cancer cells (A549)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IC 
    <sub>50</sub> = 26.82 µg/mL 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B38-molecules-26-00943" ref-type="bibr">38</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Phycocyanin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Limnothrix</i> sp. 
    <br/>37-2-1 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Fractional precipitation and purification with activated charcoal and chitosan</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Prostate Cell Line LNCaP</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">C-PC alone (250 and 500 µg/mL) killed 65% and 70% of cells while C-PC (500 µg/mL) combined with Topetencan (TPT) (1 µM) killed 80% of cells due to additive effect</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B39-molecules-26-00943" ref-type="bibr">39</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Phycocyanin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Limnothrix</i> sp. 
    <br/>NS01 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Four-step purification procedure including the adsorption of impurities with chitosan, activated charcoal, ammonium sulfate precipitation, and ion-exchange chromatography</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Human breast cancer cell line (MCF-7)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IC 
    <sub>50</sub> for 24, 48 and 72 h exposure to C-PC were 5.92, 5.66 and 4.52 µg/µL 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B40-molecules-26-00943" ref-type="bibr">40</a>] 
   </td>
  </tr>
  <tr>
   <td colspan="6" align="center" valign="middle" rowspan="1">Cardioprotective agents</td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">cis β-carotene</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Dunaliella bardawil</i>
    <br/>(containing a mixture of cis and trans-isomers) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> Enriched extract </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Mice fed a high-fat diet</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">In old mice with established atherosclerotic lesion, Dunaliella inhibited significantly plasma cholesterol elevation and atherosclerosis progression</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B41-molecules-26-00943" ref-type="bibr">41</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Eicosapentanoic acid (EPA)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Nannochloropsis</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Enriched EPA oil</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Healthy subjects</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Lower cholesterol levels</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B42-molecules-26-00943" ref-type="bibr">42</a>] 
   </td>
  </tr>
  <tr>
   <td colspan="6" align="center" valign="middle" rowspan="1">Antiviral agent</td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Cyanovirin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Nostoc ellpsosporum</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Aqueous extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1 laboratory strains; 
    <br/>HIV-1 primary isolates; 
    <br/>HIV-2; 
    <br/>SIV; 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1 laboratory strains (EC 
    <sub>50</sub> 0.1–5.8 nM), HIV-1 primary isolates (EC 
    <sub>50</sub> 1.5–36.8 nM), HIV-2 (EC 
    <sub>50</sub> 2.3–7.6 nM), SIV (EC 
    <sub>50</sub> 11 nM) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B43-molecules-26-00943" ref-type="bibr">43</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Scytovirin</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Scytonema varium</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Aqueous extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1 laboratory strain (HIV-1 
    <sub>RF</sub>); 
    <br/>HIV-1 primary isolates (ROJO) in peripheral blood mononuclear cell (PBMC); 
    <br/>HIV-1 primary isolates (Ba-L and ADA) in macrophages 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1 
    <sub>RF</sub> (EC 
    <sub>50</sub> 0.3 nM), 
    <br/>HIV-1 primary isolates (ROJO) in PBMC (EC 
    <sub>50</sub> 7 nM), HIV-1 primary isolates (Ba-L) (EC 
    <sub>50</sub> 22 nM), HIV-1 primary isolates (ADA) (EC 
    <sub>50</sub> 17 nM) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B44-molecules-26-00943" ref-type="bibr">44</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Mixture of Icthypeptins A and Icthypeptins</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Microcystic ichthyoblabe</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Methanol extract</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Influenza A</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IC 
    <sub>50</sub> 12.5 µg/mL 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B45-molecules-26-00943" ref-type="bibr">45</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Calcium spirulan</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Spirulina platensis</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Aqueous extraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1; 
    <br/>Herpes simplex virus type 1 (HSV-1) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HIV-1 (IC 
    <sub>50</sub> 9.3 µg/mL), 
    <br/>Herpes simplex virus type 1 (HSV-1) (IC 
    <sub>50</sub> 9.0 µg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B46-molecules-26-00943" ref-type="bibr">46</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulfated exopolysaccharide</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <i>Porphyridium cruentum</i>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extraction</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herpes simplex virus type 1 (HSV-1); 
    <br/>Herpes simplex virus type 2 (HSV-2); 
    <br/>Vericella virus (VZV) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-1 (CPE 
    <sub>50</sub> protection 1 µg/mL), HSV-2 (CPE 
    <sub>50</sub> protection 5 µg/mL), VZV (CPE 
    <sub>50</sub> protection 0.7 µg/mL). 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B47-molecules-26-00943" ref-type="bibr">47</a>] 
   </td>
  </tr>
 </tbody>
</table>
